Validation of Constant Work Rate Cycling Endurance Time for Use in Chronic Obstructive Pulmonary Disease Clinical Trials.
Saved in:
| Title: | Validation of Constant Work Rate Cycling Endurance Time for Use in Chronic Obstructive Pulmonary Disease Clinical Trials. |
|---|---|
| Authors: | Casaburi R; Rehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California., Merrill D; COPD Foundation, Miami, Florida., Leidy NK; Evidera, Bethesda, Maryland., Locantore N; COPD Foundation, Miami, Florida., Dolmage T; Respiratory Diagnostic & Evaluation Services and Respiratory Medicine, West Park Healthcare Centre, Toronto, Ontario, Canada., Garcia-Aymerich J; ISGlobal, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain., Goldstein R; Department of Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada., Harding G; Evidera, Bethesda, Maryland., Maltais F; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, Quebec, Canada., O'Donnell D; Respiratory Investigation Unit, Department of Medicine, Queen's University and Kingston Health Sciences Centre, Kingston, Ontario, Canada., Porszasz J; Rehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California., Puente-Maestu L; Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain., Rennard S; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Rossiter HB; Rehabilitation Clinical Trials Center, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California., Sciurba F; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania., Spruit MA; Department of Research & Development, CIRO, Horn, the Netherlands.; Department of Respiratory Medicine, Maastricht University Medical Centre, NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands., Tal-Singer R; TalSi Translational Medicine Consulting, LLC, Media, Pennsylvania., Tetzlaff K; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; Department of Sports Medicine, University of Tübingen, Tübingen, Germany; and., Van't Hul A; Department of Respiratory Diseases, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Yu R; Evidera, Bethesda, Maryland., Hamilton A; COPD Foundation, Miami, Florida. |
| Source: | Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 May; Vol. 21 (5), pp. 727-739. |
| Publication Type: | Journal Article; Validation Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Thoracic Society Country of Publication: England NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2325-6621 |
|---|---|
| DOI: | 10.1513/AnnalsATS.202305-480OC |
